A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is treatable, and the earlier it is detected, the better the treatment outcome.

ORLANDO, Fla. (AP) _ A common blood-scanning test for prostate cancer, an annual medical ritual for millions of older men, can safely be done less frequently for the majority who have low readings, a ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

Q: I am 84 years old and just got a new doctor. When I asked her about the prostate exam my previous doctor did every few years, she seemed dismissive, saying, “Oh, we don’t do that anymore.” Is this ...

The understanding of prostate cancer has significantly evolved in the past 15 years. However, many people—including primary care providers—may not be aware of the current guidelines for prostate ...

This article was reviewed by Darragh O’Carroll, MD. Prostate-specific antigen (PSA) is a term you’ll probably become familiar with once you start getting screened regularly for prostate cancer ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Government will consider committee’s guidance that says mass screening ‘likely to cause more harm than good’ ...

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...